Skip to main content

Drugs Made In America Acquisition Corp.

DMAAR
Exchange
Nasdaq
Industry
Blank Checks
SEC CIK
0002028614

No open-market purchases or sales by Drugs Made In America Acquisition Corp. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $1.30M in total; no superinvestor holds it.

Other share classesDMAADMAAU

13F holders, Q2 2026

Institutional positions in Drugs Made In America Acquisition Corp. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
28
−7 vs. Q1 2026
Shares held
11.6M
−3.18M (−21.5%) vs. Q1 2026
Total value
$1.30M
+$414.8K (+46.7%) vs. Q1 2026
New holders
2
3 more added
Sold out
9
8 more reduced

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DMAAR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 28 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 19 institutionsQ2 2025: 24 institutionsQ3 2025: 32 institutionsQ4 2025: 32 institutionsQ1 2026: 35 institutionsQ2 2026: 28 institutions
Value heldQ2 2026: $1.30M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $2.53MQ2 2025: $2.22MQ3 2025: $7.10MQ4 2025: $3.07MQ1 2026: $887.4KQ2 2026: $1.30M
Institutions holding DMAAR and their total value by quarter
QuarterHoldersValue
Q2 202628$1.30M
Q1 202635$887.4K
Q4 202532$3.07M
Q3 202532$7.10M
Q2 202524$2.22M
Q1 202519$2.53M
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Drugs Made In America Acquisition Corp.; share changes are against Q1 2026.

Institutions holding DMAAR in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Polar Asset Management Partners Inc.1,900,000$209.0K0.00%00.0%Unchanged
Linden Advisors LP850,000$97.8K0.00%00.0%Unchanged
Mangrove Partners850,000$93.5K0.01%00.0%Unchanged
Toronto Dominion Bank800,000$88.0K0.00%+110,000+15.9%Added
Hudson Bay Capital Management LP758,719$83.5K0.00%−942,827−55.4%Reduced
Clear Street Group Inc.711,088$78.2K0.00%−829−0.1%Reduced
Highbridge Capital Management LLC857,493$77.3K0.00%−186,826−17.9%Reduced
Rivernorth Capital Management, LLC417,998$62.7K0.00%00.0%Unchanged
Boothbay Fund Management, LLC529,898$58.3K0.00%−165,329−23.8%Reduced
LMR Partners LLP500,000$55.0K0.00%00.0%Unchanged
Westchester Capital Management, LLC500,000$55.0K0.00%00.0%Unchanged
Alpine Global Management, LLC500,000$55.0K0.01%+137,500+37.9%Added
Wolverine Asset Management LLC471,683$51.9K0.00%−221,453−31.9%Reduced
Whitebox Advisors LLC400,000$44.0K0.00%00.0%Unchanged
CNH Partners LLC372,322$37.2K0.00%00.0%Unchanged
Shaolin Capital Management LLC300,000$33.0K0.00%−150,000−33.3%Reduced
CSS LLC31,250$27.5K0.00%00.0%Unchanged
Context Capital Management, LLC201,016$22.1K0.00%00.0%Unchanged
Radcliffe Capital Management, L.P.143,911$16.5K0.00%−87,640−37.8%Reduced
DLD Asset Management, LP126,594$13.9K0.00%+25,000+24.6%Added
BNP Paribas Arbitrage, SA119,686$13.2K0.00%00.0%Unchanged
Periscope Capital Inc.75,000$8.25K0.00%00.0%Unchanged
Lineage Point Capital LP50,000$5.50K0.00%00.0%Unchanged
Gabelli Funds LLC49,300$5.42K0.00%00.0%Unchanged
Gabelli & Co Investment Advisers, Inc.48,100$5.29K0.00%00.0%Unchanged
Readystate Asset Management LP31,200$3.43K0.00%−18,800−37.6%Reduced
T3 Companies, LLC15,000$1.65K0.00%+15,000New
UBS Group AG108$120.00%+108New
RLH Capital LLC0$00.00%−399,391−100.0%Sold out
Glazer Capital, LLC0$00.00%−297,475−100.0%Sold out
Aristeia Capital LLC0$00.00%−264,168−100.0%Sold out
Quarry LP0$00.00%−249,391−100.0%Sold out
Meteora Capital, LLC0$00.00%−182,581−100.0%Sold out
Commonwealth of Pennsylvania Public School Empls Retrmt Sys0$00.00%−117,544−100.0%Sold out
Verition Fund Management LLC0$00.00%−99,200−100.0%Sold out
Bulldog Investors, LLP0$00.00%−43,364−100.0%Sold out
StoneX Group Inc.0$00.00%−42,120−100.0%Sold out